← Browse by Condition
Medical Condition

juvenile idiopathic inflammatory myopathy jiim

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for juvenile idiopathic inflammatory myopathy jiim sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 2
1
Phase 3
1
Top Sponsors
Cabaletta Bio 1 trial
NCT06154252 Phase 2, Phase 3
Recruiting

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Enrollment
74 pts
Location
United States, Unite...
Sponsor
Cabaletta Bio
View Trial →